Cargando…
Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia
BACKGROUND/AIM: Radiofrequency catheter ablation (RFA) is the most effective method of supraventricular tachycardia therapy. Recurrent supraventricular tachycardia causes systolic dysfunction and dilated cardiomyopathy. The aim of this study was to evaluate the long-term alterations of atrial and ve...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203167/ https://www.ncbi.nlm.nih.gov/pubmed/33021754 http://dx.doi.org/10.3906/sag-2005-254 |
_version_ | 1783708112842129408 |
---|---|
author | AYKAN, Ahmet Çağrı KARABAY, Can Yücel YILDIZ, Mustafa |
author_facet | AYKAN, Ahmet Çağrı KARABAY, Can Yücel YILDIZ, Mustafa |
author_sort | AYKAN, Ahmet Çağrı |
collection | PubMed |
description | BACKGROUND/AIM: Radiofrequency catheter ablation (RFA) is the most effective method of supraventricular tachycardia therapy. Recurrent supraventricular tachycardia causes systolic dysfunction and dilated cardiomyopathy. The aim of this study was to evaluate the long-term alterations of atrial and ventricular functions after RFAof typical atrioventricular nodal reentrant tachycardia (AVNRT). MATERIALS AND METHODS: This cross-sectional study included 55 consecutive patients with symptomatic drug-resistant AVNRT who had had an invasive electrophysiology study and RFA. Speckle-tracking–based echocardiographic assessment was performed shortly before and 1 year after the operation. Left ventricle (LV) and right ventricle (RV) peak systolic strain (PSS) and atrial strain measurements were performed. RESULTS: RFA successfully eliminatedtachyarrhythmia in all patients. LV apical 4-chamber PSS –20.8% (–24.7 to –16.0) vs. –22.8% (–26.6 to –17.0, P < 0.001), LV apical 2-chamber PSS –21.5% (–26.8 to –10.1) vs. –22.0% (–27.8 to –13.7, P < 0.001), LV global PSS –20.4% (–26.4 to –14.4) vs. –23.0% (–27.1 to –2.3, P < 0.001), RV global PSS –26.0% (–30.0 to –18.0) vs. –26.5% (–32.1 to –19.7, P < 0.001), and peak left atrial longitudinal strain 41.0% (19.0–71.8) vs. 54.0% (25.6–82.0, P < 0.001) were significantly improved 1 year after RFA. CONCLUSION: RFA of AVNRT not only provides relief of palpitations but also improves cardiac functions. |
format | Online Article Text |
id | pubmed-8203167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Scientific and Technological Research Council of Turkey |
record_format | MEDLINE/PubMed |
spelling | pubmed-82031672021-06-24 Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia AYKAN, Ahmet Çağrı KARABAY, Can Yücel YILDIZ, Mustafa Turk J Med Sci Article BACKGROUND/AIM: Radiofrequency catheter ablation (RFA) is the most effective method of supraventricular tachycardia therapy. Recurrent supraventricular tachycardia causes systolic dysfunction and dilated cardiomyopathy. The aim of this study was to evaluate the long-term alterations of atrial and ventricular functions after RFAof typical atrioventricular nodal reentrant tachycardia (AVNRT). MATERIALS AND METHODS: This cross-sectional study included 55 consecutive patients with symptomatic drug-resistant AVNRT who had had an invasive electrophysiology study and RFA. Speckle-tracking–based echocardiographic assessment was performed shortly before and 1 year after the operation. Left ventricle (LV) and right ventricle (RV) peak systolic strain (PSS) and atrial strain measurements were performed. RESULTS: RFA successfully eliminatedtachyarrhythmia in all patients. LV apical 4-chamber PSS –20.8% (–24.7 to –16.0) vs. –22.8% (–26.6 to –17.0, P < 0.001), LV apical 2-chamber PSS –21.5% (–26.8 to –10.1) vs. –22.0% (–27.8 to –13.7, P < 0.001), LV global PSS –20.4% (–26.4 to –14.4) vs. –23.0% (–27.1 to –2.3, P < 0.001), RV global PSS –26.0% (–30.0 to –18.0) vs. –26.5% (–32.1 to –19.7, P < 0.001), and peak left atrial longitudinal strain 41.0% (19.0–71.8) vs. 54.0% (25.6–82.0, P < 0.001) were significantly improved 1 year after RFA. CONCLUSION: RFA of AVNRT not only provides relief of palpitations but also improves cardiac functions. The Scientific and Technological Research Council of Turkey 2021-04-30 /pmc/articles/PMC8203167/ /pubmed/33021754 http://dx.doi.org/10.3906/sag-2005-254 Text en Copyright © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Article AYKAN, Ahmet Çağrı KARABAY, Can Yücel YILDIZ, Mustafa Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title | Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title_full | Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title_fullStr | Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title_full_unstemmed | Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title_short | Evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
title_sort | evaluation of cardiac functions after catheter ablation of atrioventricular nodal reentrant tachycardia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203167/ https://www.ncbi.nlm.nih.gov/pubmed/33021754 http://dx.doi.org/10.3906/sag-2005-254 |
work_keys_str_mv | AT aykanahmetcagrı evaluationofcardiacfunctionsaftercatheterablationofatrioventricularnodalreentranttachycardia AT karabaycanyucel evaluationofcardiacfunctionsaftercatheterablationofatrioventricularnodalreentranttachycardia AT yildizmustafa evaluationofcardiacfunctionsaftercatheterablationofatrioventricularnodalreentranttachycardia |